Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research results from Palacky University, Medical Department update understanding of breast cancer
October 23rd, 2008
"Among other actions, chemotherapy may induce an activation of systemic inflammatory and immune response. Urinary neopterin was evaluated, using high-performance liquid chromatography, before and during dose-dense combination chemotherapy with doxorubicin, cyclophosphamide and sequential paclitaxel (neoadjuvant or adjuvant) in 194 patients with breast carcinoma," researchers in Olomouc, Czech Republic report. "Hemoglobin, peripheral blood cell count and, in a subgroup of patients, iron metabolism were also evaluated. Urinary neopterin increased significantly during the chemotherapy. The increase in urinary neopterin was accompanied by a gradual decrease of hemoglobin. A...
Source: Women's Health Weekly (2008-10-23)
|
